Inventory Summary of ResMed Inc.

ResMed Inc.'s latest annual inventory in 2024 was 822.25 Million USD , down -17.61% from previous year.
ResMed Inc.'s latest quarterly inventory in 2024 FY was 822.25 Million USD , down -17.61% from previous quarter.
ResMed Inc. reported annual inventory of 998.01 Million USD in 2023, up 34.16% from previous year.
ResMed Inc. reported annual inventory of 743.91 Million USD in 2022, up 62.77% from previous year.
ResMed Inc. reported quarterly inventory of 933.21 Million USD for 2024 Q2, down -2.61% from previous quarter.
ResMed Inc. reported quarterly inventory of 822.25 Million USD for 2024 Q4, down -0.87% from previous quarter.

Annual Inventory Chart of ResMed Inc. (2024 - 1993)

Historical Annual Inventory of ResMed Inc. (2024 - 1993)

Year	Inventory	Inventory Growth
2024	822.25 Million USD	-17.61%
2023	998.01 Million USD	34.16%
2022	743.91 Million USD	62.77%
2021	457.03 Million USD	9.62%
2020	416.91 Million USD	19.24%
2019	349.64 Million USD	30.12%
2018	268.7 Million USD	0.14%
2017	268.31 Million USD	19.54%
2016	224.45 Million USD	-9.08%
2015	246.85 Million USD	49.23%
2014	165.41 Million USD	13.42%
2013	145.84 Million USD	-16.35%
2012	174.35 Million USD	-13.16%
2011	200.77 Million USD	8.15%
2010	185.64 Million USD	17.92%
2009	157.43 Million USD	-0.52%
2008	158.25 Million USD	0.67%
2007	157.2 Million USD	35.29%
2006	116.19 Million USD	30.4%
2005	89.1 Million USD	59.7%
2004	55.79 Million USD	12.98%
2003	49.38 Million USD	19.95%
2002	41.17 Million USD	37.27%
2001	29.99 Million USD	89.81%
2000	15.8 Million USD	47.68%
1999	10.7 Million USD	40.79%
1998	7.6 Million USD	31.03%
1997	5.8 Million USD	-4.92%
1996	6.1 Million USD	38.64%
1995	4.4 Million USD	340.0%
1994	1 Million USD	0.0%
1993	1 Million USD	0.0%

Year	Inventory	Inventory Growth
2024 FY	822.25 Million USD	-17.61%
2024 Q2	933.21 Million USD	-2.61%
2024 Q4	822.25 Million USD	-0.87%
2024 Q1	958.23 Million USD	-3.99%
2024 Q3	829.45 Million USD	-11.12%
2023 FY	998.01 Million USD	34.16%
2023 Q4	998.01 Million USD	-1.31%
2023 Q2	988.95 Million USD	14.35%
2023 Q3	1.01 Billion USD	2.26%
2023 Q1	864.85 Million USD	16.26%
2022 FY	743.91 Million USD	62.77%
2022 Q1	506.64 Million USD	10.86%
2022 Q2	592.14 Million USD	16.88%
2022 Q3	664.94 Million USD	12.29%
2022 Q4	743.91 Million USD	11.88%
2021 Q3	484.06 Million USD	1.95%
2021 Q2	474.82 Million USD	-0.67%
2021 Q1	478 Million USD	14.65%
2021 FY	457.03 Million USD	9.62%
2021 Q4	457.03 Million USD	-5.58%
2020 Q1	357.03 Million USD	2.11%
2020 FY	416.91 Million USD	19.24%
2020 Q3	358.77 Million USD	-5.03%
2020 Q4	416.91 Million USD	16.21%
2020 Q2	377.78 Million USD	5.81%
2019 Q4	349.64 Million USD	9.29%
2019 Q1	282.55 Million USD	5.16%
2019 FY	349.64 Million USD	30.12%
2019 Q3	319.93 Million USD	7.9%
2019 Q2	296.51 Million USD	4.94%
2018 Q2	296.06 Million USD	-1.47%
2018 Q3	288.7 Million USD	-2.49%
2018 Q1	300.47 Million USD	11.98%
2018 Q4	268.7 Million USD	-6.93%
2018 FY	268.7 Million USD	0.14%
2017 Q1	253.82 Million USD	13.09%
2017 Q3	259.87 Million USD	2.67%
2017 Q4	268.31 Million USD	3.25%
2017 FY	268.31 Million USD	19.54%
2017 Q2	253.1 Million USD	-0.28%
2016 Q3	232.93 Million USD	-1.91%
2016 Q1	258.6 Million USD	4.76%
2016 Q2	237.46 Million USD	-8.18%
2016 Q4	224.45 Million USD	-3.64%
2016 FY	224.45 Million USD	-9.08%
2015 Q1	197.22 Million USD	19.23%
2015 FY	246.85 Million USD	49.23%
2015 Q3	225.19 Million USD	3.27%
2015 Q4	246.85 Million USD	9.62%
2015 Q2	218.06 Million USD	10.56%
2014 Q3	164.88 Million USD	-7.41%
2014 Q2	178.07 Million USD	1.55%
2014 Q1	175.35 Million USD	20.23%
2014 Q4	165.41 Million USD	0.32%
2014 FY	165.41 Million USD	13.42%
2013 Q3	166.48 Million USD	-14.54%
2013 Q4	145.84 Million USD	-12.4%
2013 FY	145.84 Million USD	-16.35%
2013 Q2	194.8 Million USD	0.84%
2013 Q1	193.17 Million USD	10.79%
2012 Q3	183.48 Million USD	-0.51%
2012 Q2	184.42 Million USD	-1.88%
2012 Q1	187.95 Million USD	-6.39%
2012 Q4	174.35 Million USD	-4.98%
2012 FY	174.35 Million USD	-13.16%
2011 FY	200.77 Million USD	8.15%
2011 Q4	200.77 Million USD	-2.06%
2011 Q3	205 Million USD	-4.6%
2011 Q2	214.88 Million USD	0.32%
2011 Q1	214.2 Million USD	15.39%
2010 Q1	175.1 Million USD	11.23%
2010 FY	185.64 Million USD	17.92%
2010 Q2	182.87 Million USD	4.43%
2010 Q4	185.64 Million USD	-6.15%
2010 Q3	197.81 Million USD	8.17%
2009 Q3	147.67 Million USD	3.22%
2009 Q1	145.59 Million USD	-8.0%
2009 Q2	143.06 Million USD	-1.74%
2009 FY	157.43 Million USD	-0.52%
2009 Q4	157.43 Million USD	6.61%
2008 Q2	166.4 Million USD	-0.4%
2008 Q1	167.07 Million USD	6.28%
2008 Q4	158.25 Million USD	-6.63%
2008 Q3	169.48 Million USD	1.85%
2008 FY	158.25 Million USD	0.67%
2007 Q1	122.96 Million USD	5.83%
2007 Q3	156.91 Million USD	10.6%
2007 FY	157.2 Million USD	35.29%
2007 Q4	157.2 Million USD	0.18%
2007 Q2	141.87 Million USD	15.38%
2006 Q4	116.19 Million USD	6.85%
2006 FY	116.19 Million USD	30.4%
2006 Q3	108.74 Million USD	1.14%
2006 Q2	107.52 Million USD	6.58%
2006 Q1	100.88 Million USD	13.22%
2005 Q4	89.1 Million USD	18.09%
2005 Q1	61.14 Million USD	9.58%
2005 FY	89.1 Million USD	59.7%
2005 Q2	64.85 Million USD	6.07%
2005 Q3	75.45 Million USD	16.35%
2004 FY	55.79 Million USD	12.98%
2004 Q4	55.79 Million USD	-2.88%
2004 Q3	57.45 Million USD	1.04%
2004 Q2	56.86 Million USD	1.59%
2004 Q1	55.97 Million USD	13.34%
2003 FY	49.38 Million USD	19.95%
2003 Q4	49.38 Million USD	0.16%
2003 Q3	49.3 Million USD	8.55%
2003 Q2	45.42 Million USD	0.75%
2003 Q1	45.08 Million USD	9.5%
2002 Q3	33.68 Million USD	0.6%
2002 FY	41.17 Million USD	37.27%
2002 Q1	32.44 Million USD	8.18%
2002 Q2	33.47 Million USD	3.18%
2002 Q4	41.17 Million USD	22.25%
2001 Q3	28.67 Million USD	44.89%
2001 FY	29.99 Million USD	89.81%
2001 Q2	19.79 Million USD	21.72%
2001 Q1	16.25 Million USD	2.89%
2001 Q4	29.99 Million USD	4.6%
2000 Q2	15.9 Million USD	13.57%
2000 Q4	15.8 Million USD	-9.37%
2000 Q1	14 Million USD	30.84%
2000 Q3	17.43 Million USD	9.65%
2000 FY	15.8 Million USD	47.68%
1999 Q2	10.6 Million USD	12.77%
1999 Q1	9.4 Million USD	23.68%
1999 Q4	10.7 Million USD	7.0%
1999 FY	10.7 Million USD	40.79%
1999 Q3	10 Million USD	-5.66%
1998 Q4	7.6 Million USD	5.56%
1998 FY	7.6 Million USD	31.03%
1998 Q1	6.3 Million USD	8.62%
1998 Q2	7.6 Million USD	20.63%
1998 Q3	7.2 Million USD	-5.26%
1997 Q1	6.1 Million USD	0.0%
1997 FY	5.8 Million USD	-4.92%
1997 Q3	5.2 Million USD	-8.77%
1997 Q2	5.7 Million USD	-6.56%
1997 Q4	5.8 Million USD	11.54%
1996 Q3	6.1 Million USD	0.0%
1996 Q4	6.1 Million USD	0.0%
1996 FY	6.1 Million USD	38.64%
1995 FY	4.4 Million USD	340.0%
1995 Q4	4.4 Million USD	0.0%
1994 Q4	1 Million USD	0.0%
1994 FY	1 Million USD	0.0%
1993 FY	1 Million USD	0.0%
1993 Q4	1 Million USD	0.0%

Peer Inventory Comparison of ResMed Inc.

Name	Inventory	Inventory Difference
Alcon Inc.	2.32 Billion USD	64.577%
AptarGroup, Inc.	513.05 Million USD	-60.266%
Baxter International Inc.	2.82 Billion USD	70.883%
Becton, Dickinson and Company	3.27 Billion USD	74.878%
Bausch + Lomb Corporation	1.02 Billion USD	20.015%
Haemonetics Corporation	317.2 Million USD	-159.22%
Envista Holdings Corp	258.8 Million USD	-217.716%
Teleflex Incorporated	626.21 Million USD	-31.305%
Warby Parker Inc.	62.23 Million USD	-1221.223%
West Pharmaceutical Services, Inc.	434.7 Million USD	-89.153%

Global Stocks Search

ResMed Inc. (RMD)

Inventory Summary of ResMed Inc.

Annual Inventory Chart of ResMed Inc. (2024 - 1993)

Historical Annual Inventory of ResMed Inc. (2024 - 1993)

Peer Inventory Comparison of ResMed Inc.